GLP-1 agonists and exercise: comparative and combined effects Direct comparisons reveal that GLP-1RAs generally produce greater short-term weight loss than exercise alone, but exercise is superior for maintaining lean mass and cardiorespiratory fitness (16, 17, 19)
GLP-1 side effects are typically gastrointestinal (nausea, constipation, diarrhea) and often subside as the body adjusts to the medication
Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage
Moxit Shah, DM Endocrinology Consultant Endocrinologist | Ahmedabad Appointment: 9979992797 Introduction For years, people struggling with obesity were told to eat less and exercise more. While healthy lifestyle changes remain the foundation of weight management, modern science has shown that obesity is a chronic hormonal disease , not simply a lack of willpower
